Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients

Author： Pozzetto U. Citterio F. Romagnoli J. Scata M.C. Nanni G. Castagneto M.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.34, Iss.5, 2002-08, pp. : 1740-1742

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transforming Growth Factor-beta

By Cox D.A. Maurer T.

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 25-30

Academic Press

Access to resources Recommend Favorite

The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases

By Prud'homme G.J. Piccirillo C.A.

Journal of Autoimmunity, Vol. 14, Iss. 1, 2000-02 ,pp. : 23-42

Academic Press

Access to resources Recommend Favorite

Transforming growth factor-beta: A target for cancer therapy

By Kelly Ronan J. Morris John C.

Journal of Immunotoxicology, Vol. 7, Iss. 1, 2010-03 ,pp. : 15-26

Informa Healthcare

Access to resources Recommend Favorite

Correlation of plasma transforming growth factor beta 1 with asthma control test

By Ozyilmaz Ezgi Canbakan Sema Capan Nermin Erturk Arzu Gulhan Meral

Allergy and Asthma Proceedings, Vol. 30, Iss. 1, 2009-01 ,pp. : 35-40

OceanSide Publications, Inc

Access to resources Recommend Favorite

Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone?

By Jensen P. Hansen S. Moller B. Leivestad T. Pfeffer P. Fauchald P.

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1120-1120

Elsevier

Access to resources Recommend Favorite